At the close on September 4, 2026, Sanofi stock finished at EUR 149.80 on Euronext Paris, down 2.06%

Sanofi stock gains support from a regulatory vaccine update and a market value of EUR 91.49 billion

For thousands of rare disease patients who spent years before the correct diagnosis, a new AI-powered tool introduced in India has turned out to be useful by saving crucial time to detect the condition, according to people familiar with such diseases.

Sanofi stock is trading without major swings as investors weigh recent clinical data from the compan

Sanofi stock is trading with a stable valuation while analysts lift their 2026 estimates, giving inv

Sanofi stock is trading with 2026 analyst estimates of EPS 4.99 USD and revenue 12.3 billion USD in

The Korea Disease Control and Prevention Agency (KDCA) said it has secured sufficient influenza vaccine doses for the National Immunization Program (NIP), despite delays in initial deliveries from Sanofi that raised concerns about potential shortages.The agency said it replaced the affected governme

Its experimental multiple sclerosis treatment succeeded in a pair of studies.

Sanofi is Proud to Welcome New Executive Committee / Belén Garijo, Brendan O'Callaghan, cancer, François-Xavier Roger, Jamie Haney, Manuela Buxo, OncoDaily,